Zhihong Chen, Zhenyuan Zhao, Teng Xu, Feng Zou, Yuemei Yang, Peng Lu, Yiren Chen, Zaiou Zhu, Yao He, Yunong Wu, Xu Ding, Xiaomeng Song
{"title":"NUTF2 Promotes Proliferation of Oral Squamous Cell Carcinoma Through PI3K/AKT Signaling Pathway.","authors":"Zhihong Chen, Zhenyuan Zhao, Teng Xu, Feng Zou, Yuemei Yang, Peng Lu, Yiren Chen, Zaiou Zhu, Yao He, Yunong Wu, Xu Ding, Xiaomeng Song","doi":"10.1111/odi.15326","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Oral squamous cell carcinoma (OSCC) is associated with a poor prognosis. Nuclear transport factor 2 (NUTF2) participates in nucleoprotein transport. However, the mechanism of NUTF2 in OSCC remains unclear.</p><p><strong>Methods: </strong>We conducted a retrospective study in which patients had not received preoperative chemoradiotherapy and all oral lesions were primary. We assessed the NUTF2 expression in OSCC patients' tissues by polymerase chain reaction and western blot. Immunohistochemical staining was performed based on 203 OSCC specimens to analyze the characteristics of NUTF2 expression. Furthermore, we studied the impact of NUTF2 on OSCC cells through a CCK-8, wound healing, transwell, and flow cytometry assays. The mechanism of NUTF2 was further investigated through western blot. The effect of NUTF2 on tumor growth was confirmed in vivo.</p><p><strong>Results: </strong>NUTF2 was upregulated in OSCC tissues and related to the poor prognosis. The overexpression of NUTF2 promoted OSCC cell growth in CCK-8 and wound healing. Moreover, our results indicated that the AKT signaling pathway mediated the promoting role of NUTF2 in OSCC. These results were verified in subcutaneous neoplasia in vivo.</p><p><strong>Conclusion: </strong>Our study highlights the promoting effect of NUTF2 on OSCC proliferation and suggests its potential as a therapeutic target for molecular therapy of OSCC.</p>","PeriodicalId":19615,"journal":{"name":"Oral diseases","volume":" ","pages":"2441-2455"},"PeriodicalIF":2.9000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oral diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/odi.15326","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/22 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"DENTISTRY, ORAL SURGERY & MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Oral squamous cell carcinoma (OSCC) is associated with a poor prognosis. Nuclear transport factor 2 (NUTF2) participates in nucleoprotein transport. However, the mechanism of NUTF2 in OSCC remains unclear.
Methods: We conducted a retrospective study in which patients had not received preoperative chemoradiotherapy and all oral lesions were primary. We assessed the NUTF2 expression in OSCC patients' tissues by polymerase chain reaction and western blot. Immunohistochemical staining was performed based on 203 OSCC specimens to analyze the characteristics of NUTF2 expression. Furthermore, we studied the impact of NUTF2 on OSCC cells through a CCK-8, wound healing, transwell, and flow cytometry assays. The mechanism of NUTF2 was further investigated through western blot. The effect of NUTF2 on tumor growth was confirmed in vivo.
Results: NUTF2 was upregulated in OSCC tissues and related to the poor prognosis. The overexpression of NUTF2 promoted OSCC cell growth in CCK-8 and wound healing. Moreover, our results indicated that the AKT signaling pathway mediated the promoting role of NUTF2 in OSCC. These results were verified in subcutaneous neoplasia in vivo.
Conclusion: Our study highlights the promoting effect of NUTF2 on OSCC proliferation and suggests its potential as a therapeutic target for molecular therapy of OSCC.
期刊介绍:
Oral Diseases is a multidisciplinary and international journal with a focus on head and neck disorders, edited by leaders in the field, Professor Giovanni Lodi (Editor-in-Chief, Milan, Italy), Professor Stefano Petti (Deputy Editor, Rome, Italy) and Associate Professor Gulshan Sunavala-Dossabhoy (Deputy Editor, Shreveport, LA, USA). The journal is pre-eminent in oral medicine. Oral Diseases specifically strives to link often-isolated areas of dentistry and medicine through broad-based scholarship that includes well-designed and controlled clinical research, analytical epidemiology, and the translation of basic science in pre-clinical studies. The journal typically publishes articles relevant to many related medical specialties including especially dermatology, gastroenterology, hematology, immunology, infectious diseases, neuropsychiatry, oncology and otolaryngology. The essential requirement is that all submitted research is hypothesis-driven, with significant positive and negative results both welcomed. Equal publication emphasis is placed on etiology, pathogenesis, diagnosis, prevention and treatment.